| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.871 | 0.002 | 0.912 | Topoisomerase II inhibitor | 0.912 0.002 CID_4865 0.819 0.003 CID_69791988 0.874 0.002 CID_1689 | CID_4865 | |
| 0.871 | 0.003 | 0.871 | Caspase 3 stimulant | 0.87 0.003 CID_4865 0.846 0.004 CID_69791988 0.858 0.003 CID_1689 | ||
| 0.859 | 0.004 | 0.859 | Tubulin antagonist | 0.855 0.004 CID_4865 0.804 0.004 CID_69791988 0.771 0.004 CID_1689 | ||
| 0.842 | 0.012 | 0.854 | Apoptosis agonist | 0.854 0.01 CID_4865 0.836 0.012 CID_69791988 0.834 0.013 CID_1689 | CID_4865 | |
| 0.811 | 0.004 | 0.841 | DNA damaging | 0.801 0.004 CID_4865 0.721 0.005 CID_69791988 0.841 0.003 CID_1689 | CID_1689 | |
| 0.798 | 0.004 | 0.816 | Antimitotic | 0.816 0.004 CID_4865 0.78 0.004 CID_69791988 0.755 0.004 CID_1689 | CID_4865 | |
| 0.668 | 0.003 | 0.751 | Topoisomerase II alpha inhibitor | 0.751 0.002 CID_4865 0.641 0.003 CID_69791988 0.677 0.003 CID_1689 | CID_4865 | |
| 0.642 | 0.003 | 0.642 | Beta tubulin antagonist | 0.62 0.003 CID_4865 0.616 0.003 CID_69791988 0.592 0.003 CID_1689 | ||
| 0.638 | 0.003 | 0.83 | Alpha tubulin antagonist | 0.83 0.003 CID_4865 0.455 0.004 CID_69791988 0.58 0.004 CID_1689 | CID_4865 | |
| 0.655 | 0.029 | 0.685 | Caspase 9 stimulant | 0.685 0.026 CID_4865 0.506 0.057 CID_69791988 0.603 0.036 CID_1689 | CID_4865 | |
| 0.622 | 0.003 | 0.63 | Topoisomerase I inhibitor | 0.63 0.003 CID_4865 0.569 0.003 CID_69791988 0.623 0.003 CID_1689 | CID_4865 | |
| 0.615 | 0.004 | 0.696 | DNA intercalator | 0.696 0.004 CID_4865 0.487 0.005 CID_69791988 0.604 0.004 CID_1689 | CID_4865 | |
| 0.632 | 0.028 | 0.749 | Transcription factor NF kappa B inhibitor | 0.749 0.016 CID_4865 0.682 0.023 CID_69791988 0.703 0.02 CID_1689 | CID_4865 | |
| 0.546 | 0.005 | 0.585 | Hepatoprotectant | 0.585 0.005 CID_4865 0.49 0.007 CID_69791988 0.534 0.006 CID_1689 | CID_4865 | |
| 0.526 | 0.012 | 0.648 | Hypoxia-inducible factor 1 alpha inhibitor | 0.648 0.005 CID_4865 0.542 0.011 CID_69791988 0.634 0.006 CID_1689 | CID_4865 | |
| 0.457 | 0.035 | 0.457 | 5 Hydroxytryptamine release stimulant | 0.297 0.071 CID_4865 0.251 0.088 CID_69791988 0.453 0.036 CID_1689 | ||
| 0.42 | 0.003 | 0.601 | Keratolytic | 0.601 0.001 CID_4865 0.485 0.002 CID_69791988 0.512 0.002 CID_1689 | CID_4865 | |
| 0.434 | 0.052 | 0.498 | Immunosuppressant | 0.487 0.037 CID_4865 0.498 0.033 CID_69791988 0.448 0.048 CID_1689 | CID_69791988 | |
| 0.355 | 0.009 | 0.533 | Alkylator | 0.533 0.004 CID_4865 0.363 0.009 CID_69791988 0.409 0.007 CID_1689 | CID_4865 | |
| 0.337 | 0.011 | 0.392 | Neurotrophic factor enhancer | 0.325 0.013 CID_4865 0.29 0.021 CID_69791988 0.392 0.006 CID_1689 | CID_1689 | |
| 0.367 | 0.048 | 0.395 | Vasodilator, coronary | 0.395 0.037 CID_4865 0.332 0.065 CID_69791988 0.318 0.074 CID_1689 | CID_4865 | |
| 0.296 | 0.003 | 0.474 | Topoisomerase II beta inhibitor | 0.474 0.002 CID_4865 0.294 0.003 CID_69791988 0.347 0.002 CID_1689 | CID_4865 | |
| 0.302 | 0.029 | 0.33 | P-glycoprotein inhibitor | 0.33 0.024 CID_4865 0.283 0.032 CID_69791988 0.253 0.04 CID_1689 | CID_4865 | |
| 0.364 | 0.091 | 0.527 | 15-Lipoxygenase inhibitor | 0.31 0.125 CID_4865 0.387 0.08 CID_69791988 0.527 0.035 CID_1689 | CID_1689 | |
| 0.274 | 0.004 | 0.296 | Microtubule formation inhibitor | 0.296 0.002 CID_4865 0.274 0.004 CID_69791988 0.272 0.004 CID_1689 | CID_4865 | |
| 0.304 | 0.04 | 0.359 | Nitric oxide antagonist | 0.325 0.036 CID_4865 0.359 0.03 CID_69791988 0.339 0.033 CID_1689 | CID_69791988 | |
| 0.301 | 0.041 | 0.301 | Cyclic AMP phosphodiesterase inhibitor | 0.214 0.084 CID_4865 0.286 0.048 CID_69791988 0.26 0.059 CID_1689 | ||
| 0.242 | 0.005 | 0.243 | Antineoplastic alkaloid | 0.243 0.005 CID_4865 0.219 0.009 CID_69791988 0.241 0.005 CID_1689 | CID_4865 | |
| 0.298 | 0.062 | 0.459 | Antioxidant | 0.335 0.05 CID_4865 0.459 0.025 CID_69791988 0.425 0.031 CID_1689 | CID_69791988 | |
| 0.283 | 0.054 | 0.305 | Vasodilator | 0.283 0.054 CID_4865 0.302 0.047 CID_69791988 0.305 0.046 CID_1689 | CID_1689 | |
| 0.252 | 0.048 | 0.252 | Sigma receptor agonist | 0.143 0.09 CID_4865 0.232 0.053 CID_1689 | ||
| 0.245 | 0.063 | 0.354 | Pyruvate kinase inhibitor | 0.331 0.04 CID_4865 0.199 0.082 CID_69791988 0.354 0.032 CID_1689 | CID_1689 | |
| 0.216 | 0.035 | 0.332 | Melanin inhibitor | 0.318 0.02 CID_4865 0.23 0.032 CID_69791988 0.332 0.018 CID_1689 | CID_1689 | |
| 0.179 | 0.006 | 0.217 | Ornithine decarboxylase inhibitor | 0.156 0.009 CID_4865 0.217 0.004 CID_69791988 0.179 0.006 CID_1689 | CID_69791988 | |
| 0.181 | 0.01 | 0.181 | CDC-like kinase 3 inhibitor | 0.164 0.014 CID_4865 0.169 0.013 CID_1689 | ||
| 0.177 | 0.017 | 0.177 | Calcium antagonist | 0.082 0.062 CID_4865 0.086 0.059 CID_1689 | ||
| 0.213 | 0.061 | 0.32 | Non-steroidal antiinflammatory agent | 0.32 0.024 CID_69791988 0.241 0.047 CID_1689 | CID_69791988 | |
| 0.187 | 0.037 | 0.187 | Acetylcholinesterase inhibitor | 0.131 0.069 CID_4865 0.131 0.069 CID_69791988 0.165 0.047 CID_1689 | ||
| 0.173 | 0.024 | 0.173 | Alpha 2c adrenoreceptor antagonist | 0.124 0.047 CID_69791988 0.131 0.042 CID_1689 | ||
| 0.18 | 0.048 | 0.18 | CDC-like kinase 1 inhibitor | 0.139 0.078 CID_4865 0.18 0.048 CID_1689 | ||
| 0.143 | 0.016 | 0.143 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.129 0.021 CID_4865 0.141 0.017 CID_1689 | ||
| 0.128 | 0.004 | 0.128 | Endothelin receptor antagonist | 0.088 0.005 CID_4865 0.093 0.005 CID_1689 | ||
| 0.146 | 0.028 | 0.146 | Alpha 2 adrenoreceptor antagonist | 0.085 0.06 CID_69791988 0.097 0.05 CID_1689 | ||
| 0.129 | 0.014 | 0.139 | ATPase (Vacuolar H+) inhibitor | 0.135 0.012 CID_4865 0.109 0.029 CID_69791988 0.139 0.01 CID_1689 | CID_1689 | |
| 0.169 | 0.056 | 0.263 | Protein kinase stimulant | 0.207 0.039 CID_4865 0.263 0.023 CID_69791988 0.174 0.053 CID_1689 | CID_69791988 | |
| 0.146 | 0.035 | 0.21 | DNA repair enzyme inhibitor | 0.21 0.008 CID_4865 0.133 0.05 CID_69791988 0.17 0.017 CID_1689 | CID_4865 | |
| 0.231 | 0.121 | 0.362 | 12-Lipoxygenase inhibitor | 0.254 0.106 CID_69791988 0.362 0.052 CID_1689 | CID_1689 | |
| 0.193 | 0.084 | 0.193 | Psychostimulant | 0.189 0.086 CID_4865 0.14 0.126 CID_69791988 0.16 0.107 CID_1689 | ||
| 0.241 | 0.134 | 0.283 | Vasodilator, peripheral | 0.208 0.167 CID_4865 0.283 0.106 CID_69791988 0.199 0.177 CID_1689 | CID_69791988 | |
| 0.213 | 0.109 | 0.221 | Spasmolytic | 0.221 0.105 CID_4865 0.203 0.117 CID_69791988 0.178 0.138 CID_1689 | CID_4865 | |
| 0.112 | 0.011 | 0.112 | Protease activated receptor antagonist | 0.056 0.052 CID_4865 0.06 0.047 CID_69791988 0.09 0.017 CID_1689 | ||
| 0.139 | 0.044 | 0.139 | Alpha 2b adrenoreceptor antagonist | 0.091 0.084 CID_69791988 0.101 0.073 CID_1689 | ||
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR7) antagonist | 0.08 0.028 CID_4865 0.063 0.057 CID_69791988 0.096 0.013 CID_1689 | ||
| 0.113 | 0.023 | 0.113 | Phosphodiesterase XI inhibitor | 0.082 0.054 CID_4865 0.093 0.038 CID_1689 | ||
| 0.113 | 0.023 | 0.113 | Phosphodiesterase 11A inhibitor | 0.082 0.054 CID_4865 0.093 0.038 CID_1689 | ||
| 0.193 | 0.104 | 0.383 | Free radical scavenger | 0.208 0.091 CID_4865 0.383 0.032 CID_69791988 0.362 0.036 CID_1689 | CID_69791988 | |
| 0.092 | 0.004 | 0.092 | Endothelin B receptor antagonist | 0.072 0.005 CID_4865 0.067 0.005 CID_1689 | ||
| 0.157 | 0.071 | 0.157 | Cholinergic | 0.13 0.095 CID_1689 | ||
| 0.09 | 0.005 | 0.09 | Endothelin A receptor antagonist | 0.059 0.005 CID_4865 0.056 0.005 CID_1689 | ||
| 0.141 | 0.062 | 0.258 | Cyclooxygenase 1 inhibitor | 0.258 0.02 CID_4865 0.144 0.06 CID_69791988 0.168 0.048 CID_1689 | CID_4865 | |
| 0.239 | 0.16 | 0.365 | Calcium channel activator | 0.23 0.172 CID_4865 0.365 0.041 CID_69791988 | CID_69791988 | |
| 0.123 | 0.05 | 0.177 | Estrogen antagonist | 0.128 0.041 CID_4865 0.177 0.016 CID_69791988 0.15 0.023 CID_1689 | CID_69791988 | |
| 0.147 | 0.076 | 0.147 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.133 0.091 CID_1689 | ||
| 0.13 | 0.067 | 0.136 | Cyclooxygenase 3 inhibitor | 0.133 0.064 CID_4865 0.117 0.08 CID_69791988 0.136 0.061 CID_1689 | CID_1689 | |
| 0.157 | 0.095 | 0.216 | Lipocortins synthesis antagonist | 0.173 0.078 CID_4865 0.216 0.047 CID_69791988 0.168 0.083 CID_1689 | CID_69791988 | |
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.074 | 0.025 | 0.177 | Estrogen agonist | 0.067 0.027 CID_4865 0.177 0.009 CID_69791988 0.108 0.016 CID_1689 | CID_69791988 | |
| 0.137 | 0.088 | 0.17 | Adenylate cyclase stimulant | 0.155 0.054 CID_4865 0.17 0.035 CID_69791988 0.141 0.079 CID_1689 | CID_69791988 | |
| 0.089 | 0.041 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.068 | 0.023 | 0.068 | Protease activated receptor 1 antagonist | 0.05 0.032 CID_1689 | ||
| 0.132 | 0.094 | 0.29 | NOS3 expression enhancer | 0.29 0.019 CID_69791988 0.189 0.046 CID_1689 | CID_69791988 | |
| 0.099 | 0.067 | 0.132 | Estrogen receptor beta antagonist | 0.108 0.05 CID_4865 0.132 0.022 CID_69791988 0.124 0.028 CID_1689 | CID_69791988 | |
| 0.076 | 0.045 | 0.076 | Phosphodiesterase V inhibitor | |||
| 0.122 | 0.092 | 0.22 | Lipid peroxidase inhibitor | 0.161 0.061 CID_4865 0.22 0.034 CID_69791988 0.215 0.036 CID_1689 | CID_69791988 | |
| 0.143 | 0.114 | 0.179 | ATPase inhibitor | 0.165 0.077 CID_4865 0.179 0.059 CID_1689 | CID_1689 | |
| 0.068 | 0.041 | 0.09 | Dopamine D1 antagonist | 0.087 0.03 CID_69791988 0.09 0.028 CID_1689 | CID_1689 | |
| 0.053 | 0.027 | 0.056 | Factor III inhibitor | 0.05 0.035 CID_4865 0.056 0.023 CID_1689 | CID_1689 | |
| 0.113 | 0.088 | 0.139 | Cyclooxygenase 2 inhibitor | 0.139 0.062 CID_4865 0.112 0.088 CID_69791988 0.118 0.081 CID_1689 | CID_4865 | |
| 0.156 | 0.135 | 0.23 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.23 0.052 CID_4865 0.201 0.071 CID_69791988 0.195 0.076 CID_1689 | CID_4865 | |
| 0.182 | 0.161 | 0.26 | Transcription factor STAT3 inhibitor | 0.26 0.076 CID_69791988 0.203 0.13 CID_1689 | CID_69791988 | |
| 0.072 | 0.056 | 0.074 | Alpha 2a adrenoreceptor antagonist | 0.074 0.054 CID_69791988 | CID_69791988 | |
| 0.099 | 0.084 | 0.132 | Electron transport complex I inhibitor | 0.132 0.034 CID_4865 0.129 0.037 CID_69791988 | CID_4865 | |
| 0.082 | 0.07 | 0.082 | Alpha adrenoreceptor antagonist | |||
| 0.065 | 0.056 | 0.065 | Phosphodiesterase 5A inhibitor | |||
| 0.204 | 0.198 | 0.215 | Histamine release inhibitor | 0.215 0.185 CID_69791988 | CID_69791988 | |
| 0.064 | 0.059 | 0.064 | Transforming growth factor antagonist | |||
| 0.082 | 0.077 | 0.082 | Breast cancer-resistant protein inhibitor | |||
| 0.082 | 0.08 | 0.082 | Butyrylcholinesterase inhibitor | |||
| 0.098 | 0.095 | 0.098 | Acetylcholine antagonist | |||
| 0.055 | 0.053 | 0.062 | Ryanodine receptor antagonist | 0.062 0.033 CID_4865 0.057 0.047 CID_1689 | CID_4865 | |
| 0.049 | 0.047 | 0.057 | Alpha 1L adrenoreceptor antagonist | 0.057 0.026 CID_69791988 | CID_69791988 | |
| 0.066 | 0.064 | 0.107 | Na+ K+ transporting ATPase inhibitor | 0.076 0.054 CID_4865 0.107 0.025 CID_69791988 0.087 0.044 CID_1689 | CID_69791988 | |
| 0.153 | 0.154 | 0.222 | Tumour necrosis factor alpha release inhibitor | 0.222 0.091 CID_69791988 0.172 0.132 CID_1689 | CID_69791988 | |
| 0.086 | 0.087 | 0.129 | Anabolic | 0.097 0.067 CID_4865 0.129 0.032 CID_69791988 0.097 0.067 CID_1689 | CID_69791988 | |
| 0.091 | 0.095 | 0.131 | DOPA decarboxylase inhibitor | 0.096 0.085 CID_69791988 0.131 0.034 CID_1689 | CID_1689 | |
| 0.018 | 0.026 | 0.04 | Dopamine D1 agonist | 0.04 0.005 CID_69791988 0.023 0.016 CID_1689 | CID_69791988 | |
| 0.06 | 0.073 | 0.102 | Antineoplastic antibiotic | 0.102 0.045 CID_4865 0.096 0.048 CID_69791988 0.081 0.057 CID_1689 | CID_4865 | |
| 0.036 | 0.05 | 0.044 | Potassium channel Kv1.3 blocker | 0.044 0.037 CID_69791988 | CID_69791988 | |
| 0.124 | 0.139 | 0.145 | Interleukin 6 antagonist | 0.145 0.096 CID_4865 0.132 0.121 CID_1689 | CID_4865 | |
| 0.104 | 0.119 | 0.135 | Cyclooxygenase inhibitor | 0.135 0.083 CID_4865 0.115 0.105 CID_69791988 0.122 0.096 CID_1689 | CID_4865 | |
| 0.166 | 0.182 | 0.264 | Lipoxygenase inhibitor | 0.257 0.096 CID_69791988 0.264 0.091 CID_1689 | CID_1689 | |
| 0.126 | 0.142 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.154 0.033 CID_69791988 0.133 0.104 CID_1689 | CID_69791988 | |
| 0.017 | 0.034 | 0.029 | RNA-directed RNA polymerase stimulant | 0.029 0.022 CID_4865 0.026 0.024 CID_69791988 | CID_4865 | |
| 0.107 | 0.124 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.102 CID_4865 0.117 0.091 CID_1689 | CID_1689 | |
| 0.085 | 0.114 | 0.183 | Amylase inhibitor | 0.167 0.056 CID_4865 0.177 0.052 CID_69791988 0.183 0.05 CID_1689 | CID_1689 | |
| 0.047 | 0.076 | 0.065 | Nitric oxide donor | 0.065 0.04 CID_4865 | CID_4865 | |
| 0.158 | 0.187 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 CID_4865 0.172 0.165 CID_1689 | CID_4865 | |
| 0.075 | 0.105 | 0.14 | Expectorant | 0.099 0.069 CID_4865 0.14 0.04 CID_69791988 0.091 0.08 CID_1689 | CID_69791988 | |
| 0.12 | 0.152 | 0.131 | MAP kinase kinase 4 inhibitor | 0.131 0.111 CID_1689 | CID_1689 | |
| 0.063 | 0.097 | 0.086 | Insulin growth factor antagonist | 0.086 0.059 CID_69791988 | CID_69791988 | |
| 0.026 | 0.061 | 0.042 | Opioid kappa receptor agonist | 0.042 0.032 CID_69791988 | CID_69791988 | |
| 0.044 | 0.08 | 0.105 | HIV-1 integrase (3'-Processing) inhibitor | 0.103 0.025 CID_69791988 0.105 0.024 CID_1689 | CID_1689 | |
| 0.131 | 0.168 | 0.167 | Platelet antagonist | 0.167 0.128 CID_69791988 | CID_69791988 | |
| 0.033 | 0.07 | 0.062 | Aromatase inhibitor | 0.062 0.04 CID_69791988 | CID_69791988 | |
| 0.011 | 0.048 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 CID_69791988 | CID_69791988 | |
| 0.021 | 0.064 | 0.05 | Dopamine D5 antagonist | 0.05 0.025 CID_69791988 | CID_69791988 | |
| 0.059 | 0.105 | 0.076 | Insulin like growth factor 1 antagonist | 0.076 0.067 CID_69791988 | CID_69791988 | |
| 0.076 | 0.123 | 0.126 | Mucolytic | 0.106 0.069 CID_4865 0.126 0.049 CID_69791988 | CID_69791988 | |
| 0.092 | 0.138 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 CID_4865 | CID_4865 | |
| 0.036 | 0.086 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.027 CID_4865 | CID_4865 | |
| 0.034 | 0.085 | 0.088 | HIV-1 integrase (Strand Transfer) inhibitor | 0.083 0.03 CID_69791988 0.088 0.027 CID_1689 | CID_1689 | |
| 0.165 | 0.216 | 0.214 | Angiogenesis inhibitor | 0.214 0.154 CID_69791988 | CID_69791988 | |
| 0.098 | 0.155 | 0.133 | Vanilloid 1 agonist | 0.133 0.061 CID_69791988 | CID_69791988 | |
| 0.1 | 0.159 | 0.194 | Arachidonic acid antagonist | 0.194 0.039 CID_69791988 | CID_69791988 | |
| 0.008 | 0.069 | 0.064 | Estrogen receptor beta agonist | 0.064 0.017 CID_69791988 | CID_69791988 | |
| 0.053 | 0.115 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.051 CID_4865 | CID_4865 | |
| 0.057 | 0.122 | 0.091 | Estrogen receptor alpha antagonist | 0.091 0.034 CID_69791988 0.071 0.066 CID_1689 | CID_69791988 | |
| 0.065 | 0.134 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.023 CID_69791988 | CID_69791988 | |
| 0.02 | 0.095 | 0.067 | Dopamine D5 agonist | 0.067 0.009 CID_69791988 | CID_69791988 | |
| 0.058 | 0.134 | 0.16 | Prolactin inhibitor | 0.16 0.018 CID_69791988 | CID_69791988 | |
| 0.119 | 0.197 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.116 CID_69791988 | CID_69791988 | |
| 0.043 | 0.122 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 CID_69791988 | CID_69791988 | |
| 0.061 | 0.148 | 0.088 | Thioredoxin reductase inhibitor | 0.088 0.044 CID_4865 | CID_4865 | |
| 0.021 | 0.109 | 0.032 | Tubulin agonist | 0.032 0.029 CID_69791988 | CID_69791988 | |
| 0.038 | 0.128 | 0.066 | Glutamate decarboxylase inhibitor | 0.066 0.06 CID_1689 | CID_1689 | |
| 0.02 | 0.113 | 0.042 | Mannosidase inhibitor | 0.042 0.037 CID_4865 | CID_4865 | |
| 0.048 | 0.142 | 0.064 | Prolactin release inhibitor | 0.064 0.037 CID_69791988 | CID_69791988 | |
| 0.062 | 0.157 | 0.173 | Cholesterol synthesis inhibitor | 0.173 0.035 CID_69791988 | CID_69791988 | |
| 0.027 | 0.127 | 0.04 | DNA gyrase subunit A inhibitor | 0.04 0.035 CID_69791988 | CID_69791988 | |
| 0.15 | 0.252 | 0.229 | Antithrombotic | 0.229 0.145 CID_69791988 | CID_69791988 | |
| 0.029 | 0.133 | 0.065 | Dopamine agonist | 0.065 0.048 CID_69791988 | CID_69791988 | |
| 0.137 | 0.258 | 0.215 | Nitric-oxide synthase stimulant | 0.169 0.155 CID_4865 0.215 0.067 CID_69791988 0.17 0.154 CID_1689 | CID_69791988 | |
| 0.039 | 0.163 | 0.139 | Monophenol monooxygenase inhibitor | 0.139 0.051 CID_69791988 0.094 0.081 CID_1689 | CID_69791988 | |
| 0.012 | 0.136 | 0.061 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 CID_69791988 | CID_69791988 | |
| 0.043 | 0.167 | 0.084 | Glycine receptor agonist | 0.084 0.034 CID_69791988 | CID_69791988 | |
| 0.094 | 0.219 | 0.541 | Aldehyde oxidase inhibitor | 0.541 0.027 CID_69791988 | CID_69791988 | |
| 0.058 | 0.186 | 0.128 | Beta amyloid protein antagonist | 0.128 0.059 CID_69791988 | CID_69791988 | |
| 0.095 | 0.228 | 0.213 | Antiamyloidogenic | 0.213 0.091 CID_69791988 0.164 0.129 CID_1689 | CID_69791988 | |
| 0.156 | 0.29 | 0.276 | Antibacterial | 0.276 0.154 CID_69791988 0.255 0.172 CID_1689 | CID_69791988 | |
| 0.038 | 0.172 | 0.07 | Macrophage migration inhibitory factor inhibitor | 0.07 0.066 CID_1689 | CID_1689 | |
| 0.027 | 0.17 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 CID_69791988 | CID_69791988 | |
| 0.125 | 0.271 | 0.203 | Cholesterol antagonist | 0.198 0.167 CID_4865 0.203 0.162 CID_69791988 | CID_69791988 | |
| 0.098 | 0.247 | 0.19 | Succinate dehydrogenase inhibitor | 0.19 0.058 CID_69791988 | CID_69791988 | |
| 0.04 | 0.19 | 0.101 | 5-Lipoxygenase inhibitor | 0.101 0.063 CID_69791988 | CID_69791988 | |
| 0.109 | 0.259 | 0.165 | Hypoglycemic | 0.165 0.155 CID_1689 | CID_1689 | |
| 0.032 | 0.185 | 0.053 | DNA helicase inhibitor | 0.053 0.042 CID_1689 | CID_1689 | |
| 0.136 | 0.295 | 0.298 | Sodium/bile acid cotransporter inhibitor | 0.234 0.146 CID_4865 0.298 0.081 CID_69791988 | CID_69791988 | |
| 0.088 | 0.247 | 0.167 | Interferon gamma antagonist | 0.167 0.059 CID_69791988 | CID_69791988 | |
| 0.056 | 0.219 | 0.086 | Estrogen-related receptor beta agonist | 0.086 0.049 CID_69791988 | CID_69791988 | |
| 0.028 | 0.201 | 0.105 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.105 0.035 CID_69791988 | CID_69791988 | |
| 0.133 | 0.315 | 0.26 | Tyrosine 3 hydroxylase inhibitor | 0.26 0.059 CID_69791988 | CID_69791988 | |
| 0.028 | 0.211 | 0.054 | Vanilloid 2 antagonist | 0.054 0.033 CID_69791988 | CID_69791988 | |
| 0.059 | 0.244 | 0.152 | Amyloid beta aggregation inhibitor | 0.14 0.116 CID_69791988 0.152 0.106 CID_1689 | CID_1689 | |
| 0.14 | 0.331 | 0.251 | 5 Hydroxytryptamine uptake stimulant | 0.251 0.08 CID_69791988 | CID_69791988 | |
| 0.039 | 0.24 | 0.157 | Cystathionine beta-synthase inhibitor | 0.157 0.038 CID_69791988 | CID_69791988 | |
| 0.053 | 0.264 | 0.166 | Toll-Like receptor 2 antagonist | 0.166 0.042 CID_69791988 | CID_69791988 | |
| 0.109 | 0.321 | 0.204 | Transcription factor STAT inhibitor | 0.204 0.133 CID_69791988 | CID_69791988 | |
| 0.11 | 0.324 | 0.168 | RNA-directed DNA polymerase inhibitor | 0.168 0.156 CID_69791988 | CID_69791988 | |
| 0.039 | 0.265 | 0.099 | GABA C receptor antagonist | 0.099 0.08 CID_69791988 | CID_69791988 | |
| 0.038 | 0.292 | 0.101 | Bile acid receptor antagonist | 0.101 0.048 CID_69791988 | CID_69791988 | |
| 0.113 | 0.381 | 0.193 | Apoptosis antagonist | 0.193 0.189 CID_69791988 | CID_69791988 | |
| 0.032 | 0.314 | 0.099 | HIV-1 integrase (Overall Integration) inhibitor | 0.099 0.055 CID_69791988 | CID_69791988 | |
| 0.041 | 0.345 | 0.182 | Angiogenesis stimulant | 0.182 0.104 CID_69791988 | CID_69791988 | |
| 0.017 | 0.332 | 0.137 | Acetyl-CoA transferase 2 inhibitor | 0.137 0.004 CID_4865 | CID_4865 | |
| 0.057 | 0.469 | 0.192 | Superoxide dismutase inhibitor | 0.192 0.127 CID_69791988 | CID_69791988 | |
| 0.035 | 0.451 | 0.129 | Farnesoid X receptor antagonist | 0.129 0.085 CID_69791988 | CID_69791988 | |
| 0.103 | 0.521 | 0.35 | Antiinflammatory | 0.35 0.172 CID_69791988 | CID_69791988 | |
| 0.007 | 0.43 | 0.055 | Acetyl-CoA transferase inhibitor | 0.055 0.034 CID_4865 | CID_4865 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |